Drug Story

Ozempic & Obesity

7 snips
Jan 27, 2026
Dr. Fatima Cody-Stanford, an obesity medicine physician-scientist at Massachusetts General Hospital and Harvard Medical School, offers clinical perspective on obesity and GLP-1 therapies. She discusses how cheap, engineered food and industry tactics helped fuel the obesity rise. She explains how semaglutide class drugs change appetite biology and how new treatments shift stigma and economics around body weight.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Miranda's Rapid Weight Loss Experience

  • Miranda lost 144 pounds on Ozempic and describes an immediate disappearance of constant food thoughts.
  • She says the drug muted her 'food noise' but did not change her core self or confidence.
INSIGHT

Green Revolution Made Calories Cheap

  • Norman Borlaug's Green Revolution massively increased grain yields and made calories cheap and abundant.
  • This abundance enabled new ultra-processed foods and helped create the conditions for today's obesity epidemic.
INSIGHT

Tobacco Shaped Hyperpalatable Foods

  • Big Tobacco's acquisition of major food companies led to engineered, hyperpalatable foods with more sugar, salt, and carbs.
  • These products exploited biological cravings and contributed to widespread overeating.
Get the Snipd Podcast app to discover more snips from this episode
Get the app